DomaniCell, LLC is a wholly-owned subsidiary of Progenitor Cell Therapy, LLC (www.progenitorcelltherapy.com). Founded in 1997 by medical and scientific leaders in the cell therapy field, privately-held Progenitor Cell Therapy, also known as PCT, has become the leading provider of cell therapy support services to its client companies worldwide from its state-of-the-art clean room facilities and laboratories in the United States.

An ever-increasing roster of cell therapy companies and leading stem cell transplantation programs rely on PCT services. The company has served over 100 clients, performed over 30,000 cell therapy procedures involving over 17,000 units of 20+ different kinds of cell-based products, approximately 5,000 of which have already been used for patient treatment.

Headquartered in New Jersey, PCT and its subsidiary, DomaniCell, is a profitable and stable company on solid financial footing. Each parent choosing DomaniCell to collect and store their baby’s cord blood stem cells can share in the same confidence as expressed in PCT by its institutional investors and some of the world’s foremost cell therapy companies which entrust the development of their products to PCT.

As a member of the Progenitor Cell Therapy group of companies, DomaniCell is uniquely positioned to leverage internal scientific, manufacturing, and clinical expertise to benefit its partners and clientele.

Click here to learn more about Progenitor Cell Therapy.